Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin-Tazobactam for the Population with Obesity

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This study aims to evaluate the feasibility of an open randomized controlled study which would assess the proportion patients with obesity who will have a favorable pharmacodynamic parameter (i.e. fT\> 100% MIC) after 24 hours of piperacillin-tazobactam administered as a prolonged intermittent infusion compared to a standard infusion.
Epistemonikos ID: 7d12be43141cba5970c4fdec0b51c0dad6c881a8
First added on: Dec 01, 2024